On November 2 uniQure announced that the U.S. Food and Drug Administration (FDA) has accepted its application seeking approval of its gene therapy drug, which has shown historic efficacy in slowing the progression of Huntington’s disease.
...Want to keep yourself up to date with the latest news from At Risk for Huntington's Disease?
Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.
You can unsubscribe at any time painlessly.
Title of At Risk for Huntington's Disease: "At Risk for Huntington's Disease"
Is this your feed? Claim it!
On November 2 uniQure announced that the U.S. Food and Drug Administration (FDA) has accepted its application seeking approval of its gene therapy drug, which has shown historic efficacy in slowing the progression of Huntington’s disease.
...